BNTC - CIK 0001808898
The table below shows Benitec Biopharma Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2024 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $184.76M | $188.79M | $94.48M | $103.58M | $78.28M | $67.84M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $186.02M |
| $189.59M |
| $95.08M |
| $104.01M |
| $78.71M |
| $68.33M |
| Property, plant & equipment | $116.00K | $115.00K | $118.00K | $145.00K | $151.00K | $154.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $187.00M | $190.68M | $96.03M | $105.21M | $79.07M | $68.77M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $3.27M | $2.80M | $2.02M | $7.03M | $3.09M | $4.55M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $3.67M | $3.32M | $2.43M | $7.64M | $3.13M | $4.59M |
| Retained earnings | -$260.91M | -$248.98M | -$237.14M | -$212.03M | -$202.68M | -$195.32M |
| Total equity | $183.33M | $187.36M | $93.60M | $97.57M | $75.94M | $64.18M |